Literature DB >> 31611616

Neonatal and maternal outcomes of pregnancies with a fetal diagnosis of congenital heart disease using a standardized delivery room management protocol.

April D Adams1, Nimisha Aggarwal2, Melissa H Fries3, Mary T Donofrio2, Sara N Iqbal3.   

Abstract

OBJECTIVE: We sought to determine if fetuses with prenatally diagnosed congenital heart disease (CHD) were more likely to undergo cesarean delivery in the setting of a non-reassuring fetal heart rate tracing (NRFHT) and to determine if those fetuses were more likely to have a fetal acidosis. STUDY
DESIGN: A retrospective cohort study of neonates prenatally diagnosed with CHD from August 2010 to July 2016. The control group consisted of gestational age matched controls without CHD.
RESULTS: Each group consisted of 143 patients. The most common reason for cesarean delivery was a NRFHT (control 31% vs CHD 35%, p = 0.67). Fetal acidosis was a rare outcome occurring in only five controls (3.5%) and 11 cases (7.7%) (p = 0.12).
CONCLUSION: These findings demonstrate that with multidisciplinary care coordination, fetuses with a prenatal diagnosis of CHD have similar cesarean rates, labor and delivery management, and delivery room compromise as healthy fetuses.

Entities:  

Mesh:

Year:  2019        PMID: 31611616     DOI: 10.1038/s41372-019-0528-1

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  1 in total

Review 1.  Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour.

Authors:  Zarko Alfirevic; Declan Devane; Gillian Ml Gyte; Anna Cuthbert
Journal:  Cochrane Database Syst Rev       Date:  2017-02-03
  1 in total
  1 in total

1.  Delivery Outcome of Fetuses with Congenital Heart Disease-Is It Influenced by Prenatal Diagnosis?

Authors:  Alina Weissmann-Brenner; Noam Domniz; Raanan Meyer; Tal Weissbach; Tal Elkan; Yishai Salem; Yossi Bart; Eran Kassif; Boaz Weisz
Journal:  J Clin Med       Date:  2022-07-14       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.